Novel Health Strategies team is presenting studies at HTAi 2013 Annual Meeting in Seoul, South Korea on market access strategy, pricing and health economic and outcomes research trends.

These studies were led by Novel Health team and are good examples of wide breadth and depth of our expertise.

In-person replays of all presentations are available upon request.

Download PDF of Schedule

Novel's team is presenting a study titled 'Trends in Use of Health Economic Evidence for Developing Clinical Guidelines' at HTAi 2013.

This study analyzed global trends in use of health economic evidence by clinical guidelines. The results of this study show an increasing trend in citation, reference and use of HE data by medical societies.

This study will be presented on June 17 to 19, 2013 in Seoul, Korea at the 10th Annual Conference of Health Technology Assessment International (HTAi). Abstract no is 1321

Novel's team is presenting a study titled 'Impact of New Policy Changes on Need for Pharmacoeconomic Evidence for Reimbursement and Market Access' at HTAi 2013.

This study analyzed global healthcare reforms in developed and emerging markets, and assessed their impact on pricing and market access of medical products.

This study will be presented on June 17 to 19, 2013 in Seoul, Korea at the 10th Annual Conference of Health Technology Assessment International (HTAi). Abstract no is 1322